Literature DB >> 25250797

Malignant ventricular tachycardia in acromegaly: a case report.

Zhe An1, Yu-quan He1, Guo-hui Liu1, Li-li Ge1, Wen-qi Zhang1.   

Abstract

CONTEXT: In patients with acromegaly, cardiovascular complications are the main cause of death; sudden death has been associated with ventricular tachyarrhythmias. In other patients with life-threatening malignant ventricular tachyarrhythmias, surgical placement of an implantable cardioverter-defibrillator (ICD) has proved highly effective in reducing sudden death rates. CASE REPORT: The present article reports the case of a 50-year-old male acromegalic patient who presented symptoms of syncope induced by ventricular tachycardia. An ICD was surgically implanted and a pituitary adenoma, which was responsible for the acromegaly, was completely removed in the same procedure. The surgery was successful and the ventricular arrhythmias were effectively terminated. During six months of follow-up, no documented arrhythmic episodes occurred.
CONCLUSION: In patients with acromegaly, malignant ventricular tachyarrhythmia might be effectively controlled by implantation of an ICD and surgical removal of the pituitary adenoma.

Entities:  

Mesh:

Year:  2014        PMID: 25250797     DOI: 10.1590/1516-3180.2012.6410005

Source DB:  PubMed          Journal:  Sao Paulo Med J        ISSN: 1516-3180            Impact factor:   1.044


  2 in total

Review 1.  Electrophysiological features in acromegaly: re-thinking the arrhythmic risk?

Authors:  M Parolin; F Dassie; R Vettor; R P Steeds; P Maffei
Journal:  J Endocrinol Invest       Date:  2020-07-06       Impact factor: 4.256

2.  Normalization of plasma growth hormone alleviated malignant ventricular tachycardia in acromegaly.

Authors:  Zhi-Hao Liu; Kang Li; Yan-Sheng Ding; Jian-Xing Qiu; Steven Siyao Meng; Mohetaboer Momin; Sheng-Cong Liu; Tie-Ci Yi; Jian-Ping Li
Journal:  J Geriatr Cardiol       Date:  2018-08       Impact factor: 3.327

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.